Theatre 2
Information
Modality
Gene Therapy
Speakers

George Buchman
Research FellowCatalent Cell & Gene Therapy
Chris Lorenz
Chief Technical OfficerMahzi Therapeutics
Nathalie Clement
Vice President, Vector Development, Translational Gene TherapiesSiren Biotechnology
Ian Goodwin
Director of Program Design and CMC Strategy for Advanced TherapiesFUJIFILM DioSynthDocuments & Links
George Buchman
AAV End-To-End
